142 related articles for article (PubMed ID: 26788899)
1. Characterization of the Percutaneous Absorption of Ketoprofen Using the Franz Skin Finite Dose Model.
Bassani AS; Banov D; Phan H
Postgrad Med; 2016; 128(2):262-7. PubMed ID: 26788899
[TBL] [Abstract][Full Text] [Related]
2. In vitro percutaneous absorption of ketoprofen and testosterone: comparison of pluronic lecithin organogel vs. pentravan cream.
Lehman PA; Raney SG
Int J Pharm Compd; 2012; 16(3):248-52. PubMed ID: 23050302
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the in vitro human skin percutaneous absorption of ketoprofen in topical anhydrous and aqueous gels.
Ip K; Song G; Banov D; Bassani AS; Liu Y; Song H; Valdez BC
Skin Res Technol; 2024 Mar; 30(3):e13589. PubMed ID: 38396354
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a compounding phospholipid base for the percutaneous absorption of high molecular weight drugs using the Franz finite dose model.
Banov D; Song G; Carvalho M; Bassani AS; Valdez BC
Skin Res Technol; 2024 Feb; 30(2):e13610. PubMed ID: 38352988
[TBL] [Abstract][Full Text] [Related]
5. Impact of the chemical and physical stability of ketoprofen compounded in various pharmaceutical bases on its topical and transdermal delivery.
Nornoo AO; Wulz J; Yoon H; Nan Y; Lese M
Pharm Dev Technol; 2016 Mar; 21(2):204-13. PubMed ID: 25431959
[TBL] [Abstract][Full Text] [Related]
6. In-vitro transcutaneous delivery of ketoprofen and polyunsaturated fatty acids from a pluronic lecithin organogel vehicle containing fish oil.
Richards H; Thomas CP; Bowen JL; Heard CM
J Pharm Pharmacol; 2006 Jul; 58(7):903-8. PubMed ID: 16805949
[TBL] [Abstract][Full Text] [Related]
7. Preparation and in vitro evaluation of a pluronic lecithin organogel containing ricinoleic acid for transdermal delivery.
Boddu SH; Bonam SP; Wei Y; Alexander K
Int J Pharm Compd; 2014; 18(3):256-61. PubMed ID: 25306775
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the percutaneous absorption of promethazine hydrochloride, in vitro, using the human ex vivo skin model.
Bassani AS; Banov D; Lehman PA
Int J Pharm Compd; 2008; 12(3):270-3. PubMed ID: 23969717
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of a new topical gel-spray formulation of ketoprofen lysine salt in the rat: percutaneous permeation in vitro and in vivo and pharmacological activity.
Porzio S; Caselli G; Pellegrini L; Pallottini V; Del Rosario M; Coppola A; Boltri L; Gentile M; Clavenna G; Melillo G
Pharmacol Res; 1998 Jan; 37(1):41-7. PubMed ID: 9503479
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Percutaneous Absorption of Ketamine HCl, Gabapentin, Clonidine HCl, and Baclofen, in Compounded Transdermal Pain Formulations, Using the Franz Finite Dose Model.
Bassani AS; Banov D
Pain Med; 2016 Feb; 17(2):230-8. PubMed ID: 26352507
[TBL] [Abstract][Full Text] [Related]
11. Microdialysis assessment of percutaneous penetration of ketoprofen after transdermal administration to hairless rats and domestic pigs.
Shinkai N; Korenaga K; Okumura Y; Mizu H; Yamauchi H
Eur J Pharm Biopharm; 2011 Aug; 78(3):415-21. PubMed ID: 21397690
[TBL] [Abstract][Full Text] [Related]
12. [Establishment and application of in situ perfused pig ear model for percutaneous absorption].
Hu JH; Zhu QG; Shen Q
Yao Xue Xue Bao; 2003 Oct; 38(10):783-6. PubMed ID: 14730905
[TBL] [Abstract][Full Text] [Related]
13. The delivery of ketoprofen from a system containing ion-exchange fibers.
Yu L; Li S; Yuan Y; Dai Y; Liu H
Int J Pharm; 2006 Aug; 319(1-2):107-13. PubMed ID: 16701973
[TBL] [Abstract][Full Text] [Related]
14. Relative bioavailability of ketoprofen 20% in a poloxamer-lecithin organogel.
Dowling TC; Arjomand M; Lin ET; Allen LV; McPherson ML
Am J Health Syst Pharm; 2004 Dec; 61(23):2541-4. PubMed ID: 15595229
[TBL] [Abstract][Full Text] [Related]
15. Transdermal delivery of ketoprofen: the influence of drug-dioleylphosphatidylcholine interactions.
Garcia MT; da Silva CH; de Oliveira DC; Braga EC; Thomazini JA; Bentley MV
Pharm Res; 2006 Aug; 23(8):1776-85. PubMed ID: 16858649
[TBL] [Abstract][Full Text] [Related]
16. Improved percutaneous delivery of ketoprofen using combined application of nanocarriers and silicon microneedles.
Vučen SR; Vuleta G; Crean AM; Moore AC; Ignjatović N; Uskoković D
J Pharm Pharmacol; 2013 Oct; 65(10):1451-62. PubMed ID: 24028612
[TBL] [Abstract][Full Text] [Related]
17. Lecithin microemulsions for the topical administration of ketoprofen: percutaneous adsorption through human skin and in vivo human skin tolerability.
Paolino D; Ventura CA; Nisticò S; Puglisi G; Fresta M
Int J Pharm; 2002 Sep; 244(1-2):21-31. PubMed ID: 12204562
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous absorption of methimazole: an in vitro study of the absorption pharmacokinetics for two different vehicles.
Hill KE; Mills PC; Jones BR; Bolwell CF; Aberdein D; Chambers JP
J Vet Pharmacol Ther; 2015 Dec; 38(6):581-9. PubMed ID: 25683868
[TBL] [Abstract][Full Text] [Related]
19. Development of a novel ketoprofen transdermal patch: effect of almond oil as penetration enhancers on in-vitro and ex-vivo penetration of ketoprofen through rabbit skin.
Hussain A; Khan GM; Shah SU; Shah KU; Rahim N; Wahab A; Rehman AU
Pak J Pharm Sci; 2012 Jan; 25(1):227-32. PubMed ID: 22186334
[TBL] [Abstract][Full Text] [Related]
20. Topical oleo-hydrogel preparation of ketoprofen with enhanced skin permeability.
Rhee GJ; Woo JS; Hwang SJ; Lee YW; Lee CH
Drug Dev Ind Pharm; 1999 Jun; 25(6):717-26. PubMed ID: 10349557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
